Position in ENLV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$40,225
+$6,917 QoQ
Shares Held
43,253
-8.7% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENLV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtu Financial LLC holds $51,538,389 across 141 Biotechnology names. ENLV ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
70,715 | $3,728,094 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,634 | $3,408,886 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
67,775 | $2,692,023 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
54,785 | $2,204,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,479 | $2,173,678 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
262,298 | $2,011,825 | |
| 7 | KALA |
KALA BIO, Inc.
|
152,197 | $1,316,504 | |
| 8 | IMUX |
Immunic, Inc.
|
113,366 | $1,258,362 |
All Filings in ENLV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,225 | 43,253 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $33,308 | 47,381 | Shares | Defined | 2026-02-23 | |
| 2025-03-31 | $16,927 | 17,451 | Shares | Defined | 2025-05-12 | |
| 2021-09-30 | $170,914 | 17,299 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||